Antlia Bioscience, Inc.

CIK 1829522 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Antlia Bioscience, Inc..

Recent SEC filings

FiledFormAccession number
Jun 5, 2026D0001829522-26-000003
Apr 26, 2022D0001829522-22-000001
Oct 23, 2020D0001829522-20-000001